SE0004455D0 - Method of neuronal regeneration in the central nervous system - Google Patents
Method of neuronal regeneration in the central nervous systemInfo
- Publication number
- SE0004455D0 SE0004455D0 SE0004455A SE0004455A SE0004455D0 SE 0004455 D0 SE0004455 D0 SE 0004455D0 SE 0004455 A SE0004455 A SE 0004455A SE 0004455 A SE0004455 A SE 0004455A SE 0004455 D0 SE0004455 D0 SE 0004455D0
- Authority
- SE
- Sweden
- Prior art keywords
- substance
- nervous system
- central nervous
- neuronal regeneration
- ageing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2285—Endothelin, vasoactive intestinal contractor [VIC]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Disclosed is a pharmaceutical composition comprising a substance that upon administration to a patient leads to an inhibition of extension of cellular processes of astrocytes and/or a retraction of said cellular processes. Disclosed is also use of said substance for the production of a pharmaceutical composition for treatment of a condition selected from the group consisting of brain injury, spinal cord injury, stroke, neurodegenerative diseases, neuronal and/or synaptic loss associated with ageing, disorders of the brain associated with ageing and diabetic retinopathy, and also a method for treatment of said conditions wherein said substance is administered to a patient.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0004455A SE0004455D0 (en) | 2000-12-01 | 2000-12-01 | Method of neuronal regeneration in the central nervous system |
PCT/SE2001/002656 WO2002043654A2 (en) | 2000-12-01 | 2001-11-30 | Pharmaceutical composition and method for treatment of brain injury, spinal cord injury, stroke, neurodegenerative disease and other conditions |
AU2002223170A AU2002223170A1 (en) | 2000-12-01 | 2001-11-30 | Pharmaceutical composition and method for treatment of brain injury, spinal cord injury, stroke, neurodegenerative disease and other conditions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0004455A SE0004455D0 (en) | 2000-12-01 | 2000-12-01 | Method of neuronal regeneration in the central nervous system |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0004455D0 true SE0004455D0 (en) | 2000-12-01 |
Family
ID=20282072
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0004455A SE0004455D0 (en) | 2000-12-01 | 2000-12-01 | Method of neuronal regeneration in the central nervous system |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2002223170A1 (en) |
SE (1) | SE0004455D0 (en) |
WO (1) | WO2002043654A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5498571B2 (en) | 2009-04-30 | 2014-05-21 | ミッドウェスタン ユニバーシティ | A novel treatment method using a centerkin |
JP6928450B2 (en) * | 2013-07-08 | 2021-09-01 | ミッドウェスタン ユニバーシティ | Compositions and Methods for Treating Neuropsychiatric Disorders Using Endothelin B Receptor Agonists |
US20150190377A1 (en) * | 2014-01-06 | 2015-07-09 | The Regents Of The University Of California, A California Corporation | Neuronal regeneration |
WO2016172952A1 (en) | 2015-04-30 | 2016-11-03 | 江苏挪贝肽医药科技有限公司 | Application of pi4kiiiα protein and related membrane protein complex in treating alzheimer's disease |
KR20230020946A (en) * | 2020-03-31 | 2023-02-13 | 누오-베타 파마슈티컬 테크놀로지 (상하이) 씨오., 엘티디. | Deuterated oxophenylarsine compounds and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998009523A1 (en) * | 1996-09-05 | 1998-03-12 | Massachusetts Institute Of Technology | Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
WO1998029547A1 (en) * | 1996-12-31 | 1998-07-09 | The Rockefeller University | Modulators of radial glia-astrocyte differentiation and transformation, and diagnostic and therapeutic uses thereof |
DE19751949A1 (en) * | 1997-11-24 | 1999-05-27 | Bayer Ag | Neuronal regeneration and neurodegenerative disease treatment with aminomethyl-chroman derivatives |
-
2000
- 2000-12-01 SE SE0004455A patent/SE0004455D0/en unknown
-
2001
- 2001-11-30 AU AU2002223170A patent/AU2002223170A1/en not_active Abandoned
- 2001-11-30 WO PCT/SE2001/002656 patent/WO2002043654A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002043654A2 (en) | 2002-06-06 |
WO2002043654A3 (en) | 2002-09-06 |
AU2002223170A1 (en) | 2002-06-11 |
WO2002043654A8 (en) | 2004-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2021026218A3 (en) | Treatment of central nervous system disorders | |
HK1042655A1 (en) | Use of erythropoietin in the production of the drugs for the treatment of cerebral ischaemia. | |
WO2008039898A3 (en) | Methods for the treatment of a traumatic central nervous system injury | |
IL225192A (en) | Combination of dextromethorphan and quinidine for use in the treatment of mental illness, neuropathic pain or brain injury | |
ATE452652T1 (en) | TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISEASES WITH BOTULINUM TOXIN | |
ATE537872T1 (en) | DEVICE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS USING CHRONIC ADAPTIVE BRAIN STIMULATION DEPENDENT ON LOCAL BIOPOTENTIALS | |
ATE94069T1 (en) | USE OF PHYSIOLOGICALLY ACTIVE SUBSTANCES IN THE MANUFACTURE OF MEDICATIONS FOR BRAIN AND NERVE DISEASES. | |
CY1105507T1 (en) | SUBSTITUTED PYRAZOLE- AND THIAZOLOPYRIMIDINES | |
MX9304110A (en) | USE OF COMPLEMENT INHIBITORS FOR THE PREPARATION OF A MEDICATION INTENDED FOR PROPHYLAXIS AND THERAPY OF INFLAMMATORY SKIN AND CUTANEOUS DISEASES AS WELL AS PURPLE. | |
WO2004084839A3 (en) | Method and article for treatment of sensory neuron related disorders through transdermal application of botulinum toxin | |
WO2003092617A3 (en) | Combinations for the treatment of inflammatory skin disorders | |
HK1092358A1 (en) | Method for producing medicaments for reducing amyloid deposition, amyloid neurotoxicity and microgloisis | |
WO2010018996A3 (en) | Human neural stem cell, and pharmaceutical composition for the treatment of central or peripheral nervous system disorders and injuries using same | |
ES2063998T3 (en) | USE OF N-ALKYL 1,4-DIHYDROPYRIDIN-DICARBOXYL ACID ESTERS AS MEDICATIONS, NEW COMPOUNDS AND PROCEDURE FOR THEIR PREPARATION. | |
SE0004455D0 (en) | Method of neuronal regeneration in the central nervous system | |
WO2003057162A3 (en) | Combination for the treatment of immunoinflammatory disorders and proliferative skin diseases | |
BR0116653A (en) | Medicinal product containing a polyamine as active substance | |
RU2006147345A (en) | METHOD FOR TREATING DISEASES, INJURIES OF THE PERIPHERAL NERVOUS SYSTEM, THEIR CONSEQUENCES AND CONSEQUENCES OF DISTURBANCE OF SPINAL BRAIN CIRCULATION AND SPINAL INJURIES | |
ATE285773T1 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NEUROLOGICAL DISEASES | |
ATE294582T1 (en) | USE OF ALPHA-1 ADRENORECEPTOR ANTAGONISTS FOR THE PRODUCTION OF A MEDICATION FOR THE PREVENTION AND TREATMENT OF CANCER | |
WO2003030836A3 (en) | Neuronal regeneration | |
WO2001082954A3 (en) | Ceruloplasmin and uses thereof in neurodegenerative related conditions | |
JP2009532369A5 (en) | ||
EA200702534A1 (en) | APPLICATION OF A BENZOYL DERIVATIVE 3-AMINOCARBAZOLE FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH THE PROTAGLANDINE E2 (PGE2) PRODUCT | |
PT1235573E (en) | ASSOCIACAO DE RILUZOLE AND GABAPENTINA AND ITS USE AS A DRUG IN THE TREATMENT OF MOTONEURONAL DISEASES |